In Rheumatology, we have more bits of information about our patients with chronic diseases than we can manage, without help. Just one visit, for example, generates results of tests and […]
LEAP – Winter 2023: Big Data, Individualized Care
Promotions
LEAP Rounds – Holiday 2022
Our Patient-Reported Outcomes Measurement Information System-Physical Function (PROMIS PF) Minimal Disease Activity (MDA), a tool developed at Johns Hopkins and validated within our PsA cohort, allows for exquisite description of […]
LEAP Rounds – Fall 2022
In 2015, Johns Hopkins scientists proved that scleroderma is often a casualty of war: it is the unfortunate consequence of the body’s battle to fight off cancer. We have since […]
LEAP Rounds – Holiday 2021
The vast majority of the patients who take statins don’t ever have to worry about the side effect of muscle symptoms. Even among those who do experience muscle damage, with […]
LEAP Rounds – Fall 2021
A prevalent belief among rheumatologists has been that an accurate diagnosis of Sjögren’s is not essential because of the lack of disease-modifying therapies. But a correct diagnosis is very important […]
LEAP Rounds – Spring 2020
Corticosteroids (prednisone) are the mainstay of therapy for systemic lupus erythematosus (SLE). Prednisone works: it has anti-inflammatory and immunosuppressive actions in SLE. This is why doctors who treat lupus patients […]
